CIK: 0001019231 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 13, 2015
Total Value ($000): $256,447 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ZIOPHARM ONCOLOGY INC | 11,722,163 | $126,248 | 49.2% | $10.77 | — | COM | 98973P101 |
| — | INTREXON CORPORATION | 2,100,085 | $95,281 | 37.2% | $45.37 | — | COM | 46122T102 |
| — | WILLIAMS PARTNERS LP | 172,732 | $8,502 | 3.3% | $49.22 | — | LP - PUBLIC EQUITY | 96949L105 |
| — | BIO-PATH HOLDINGS INC | 3,830,882 | $6,857 | 2.7% | $2.63 | — | COM | 09057N102 |
| VOO | VANGUARD 500 INDEX FUND | 16,482 | $3,118 | 1.2% | $180.81 | — | ETFS | 922908363 |
| VEA | VANGUARD FTSE DEV MKTS | 65,465 | $2,607 | 1.0% | $39.75 | — | ETFS | 921943858 |
| VWO | VANGUARD MSCI EMERGING MKTS | 60,789 | $2,484 | 1.0% | $40.58 | — | ETFS | 922042858 |
| VOE | VANGUARD MID-CAP VALUE ETF | 26,362 | $2,423 | 0.9% | $85.13 | — | ETFS | 922908512 |
| VDE | VANGUARD ENERGY ETF | 17,109 | $1,870 | 0.7% | $127.71 | — | ETFS | 92204A306 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $1,830 | 0.7% | $25.31 | +64.9% | COM | 882508104 |
| GLD | SPDR GOLD TRUST | 15,422 | $1,753 | 0.7% | $122.11 | — | ETFS | 78463V107 |
| VNQ | VANGUARD REIT ETF | 18,503 | $1,560 | 0.6% | $72.18 | — | ETFS | 922908553 |
| — | GENERAL MOLY INC | 2,922,831 | $1,491 | 0.6% | $1.15 | — | COM | 370373102 |
| — | LEXICON PHARMACEUTICALS INC | 250,000 | $236 | 0.1% | $2.17 | — | COM | 528872104 |
| — | VITAE PHARMACEUTICALS INC | 11,100 | $130 | 0.1% | $11.71 | — | COM | 92847N103 |
| KMI | KINDER MORGAN INC/DE | 1,200 | $50 | 0.0% | $22.45 | +6.3% | COM | 49456B101 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $4 | 0.0% | $20.00 | +26.6% | COM | 736508847 |
| EFX | EQUIFAX INC. | 29 | $3 | 0.0% | $62.16 | +28.6% | COM | 294429105 |